
FIBROGEN, INC.
FGEN
![]() |
|
43.23USD | +0.39% |
Turn to zoom
Prev. | 43.0600 |
Open | 42.5700 |
High | 44.3600 |
Low | 41.3800 |
Volume | 1 752 357 |
Latest news
Chart FIBROGEN, INC.
Technical analysis trends
Short Term | Mid-Term | Long Term | |
Trend | Neutral | Neutral | Bullish |
Resistance | 44,2 | 49,0 | 48,8 |
Spread/Res. | -2,3% | -12% | -11% |
Spread/Supp. | 17% | 17% | 24% |
Support | 37,1 | 37,1 | 35,0 |
Financials
|
|
Company
FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing and commercializing a pipeline of first-in-class therapeutics. The Company applies its capabilities in hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology to advance innovative medicines...
>> Read more
>> Read more
Sector : |
Biotechnology & Medical Research - NEC
|
Calendar : |
2021-03-03 Earnings Release
|
Trading Rating : |
Investor Rating : |
Income Statement Evolution
Consensus
Mean consensus | OUTPERFORM |
Number of Analysts | 10 |
Average target price | 61,88 $ |
Last Close Price | 43,23 $ |
Spread / Highest target | 111% |
Spread / Average Target | 43,1% |
Spread / Lowest Target | 1,78% |